[Therapy of carcinoma of the kidney pelvis].
Transitional cell carcinoma of the renal pelvis is relatively uncommon, and only 5% of all urothelial carcinomas occur in the renal collecting system. Invasive tumors are often aggressive in their biological behavior and show a high tendency for systemic progression. Conservative therapy should only be considered an option in patients with imperative indications (solitary functioning kidney, bilateral tumor, renal insufficiency). In some cases, organ-sparing techniques such as open resection or endourological treatment (percutaneous or by ureteroscopy) can be performed. However, nephroureterectomy with excision of a bladder cuff is considered to be the standard treatment and should be performed whenever possible.
Hauser
S
S
Urologische Universitätsklinik, Inselspital, 3010 Bern, Schweiz.
Studer
U E
UE
D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery*; D007682:Kidney Pelvis / Q000473:pathology / Q000601:surgery*; D010535:Laparoscopy; D009367:Neoplasm Staging; D009392:Nephrectomy; D011379:Prognosis; D018666:Ureteroscopy
Therapie des Nierenbeckenkarzinoms.